Outcomes of primary surgical cytoreduction in patients with BRCA-associated high-grade serous ovarian carcinoma. - Wikidata - awgldk - TriplyDB

Outcomes of primary surgical cytoreduction in patients with BRCA-associated high-grade serous ovarian carcinoma.

Outcomes of primary surgical cytoreduction in patients with BRCA-associated high-grade serous ovarian carcinoma.

http://www.wikidata.org/entity/Q37540704

about

Germline mutations of BRCA1 gene exon 11 are not associated with platinum response neither with survival advantage in patients with primary ovarian cancer: understanding the clinical importance of one of the biggest human exons. A study of the Tumor The role of BRCA status on the prognosis of patients with epithelial ovarian cancer: a systematic review of the literature with a meta-analysis.BRCA-associated ovarian cancer: from molecular genetics to risk management Invasion patterns of metastatic high-grade serous carcinoma of ovary or fallopian tube associated with BRCA deficiency.Biologically-targeted detection of primary and micro-metastatic ovarian cancer Invasion Patterns of Metastatic Extrauterine High-grade Serous Carcinoma With BRCA Germline Mutation and Correlation With Clinical Outcomes.Characteristics of women with ovarian carcinoma who have BRCA1 and BRCA2 mutations not identified by clinical testing.Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study.Association of BRCA1/2 mutations with ovarian cancer prognosis: An updated meta-analysis.BRCA1 and BRCA2 mutations and clinical interpretation in 398 ovarian cancer patients: comparison with breast cancer variants in a similar population

P2860

Q33458308-13EC1F7E-E97A-492E-BAAC-59D727E1A28C Q33553318-23599683-1D30-448C-BD03-4AD95EF569A6 Q34032766-9032FD03-F94B-4B82-80A3-102C407EA9FA Q35104225-4540A8B2-7024-436D-8721-459453100AED Q36915331-D11E5B4D-A677-4D22-BFAC-834A61C7D5CA Q37146082-B9E9131C-1A71-4ECA-9E03-6A93B7F2B8FA Q37553583-5D8925D1-5E46-4FBF-BC14-2FA57F555FCD Q47958061-82828A3D-D887-4F3E-ACD6-B8BC9037F929 Q55377222-884FAD6F-6C71-4C03-ABB9-FDF4F0A3C4FD Q58786178-77918B8C-75A5-48DD-87F9-C7BC54D145D8

P2860

Outcomes of primary surgical cytoreduction in patients with BRCA-associated high-grade serous ovarian carcinoma.

http://www.wikidata.org/entity/Q37540704

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 May 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Outcomes of primary surgical c ...... rade serous ovarian carcinoma.

@en

Outcomes of primary surgical c ...... rade serous ovarian carcinoma.

@nl

type

label

Outcomes of primary surgical c ...... rade serous ovarian carcinoma.

@en

Outcomes of primary surgical c ...... rade serous ovarian carcinoma.

@nl

prefLabel

Outcomes of primary surgical c ...... rade serous ovarian carcinoma.

@en

Outcomes of primary surgical c ...... rade serous ovarian carcinoma.

@nl

P1433

Q37540704-51F93CD5-2948-427D-8414-E206BDE4900F

P1476

Q37540704-19B05FD7-4700-4426-80C2-800468EED9BE

P2093

Q37540704-0584F02A-EFEC-43F2-BD3C-419C181DCE4F

Q37540704-14E7A2DD-C496-4031-9CE6-E9C5D7FBADB5

Q37540704-2CC6C0C8-1829-46FB-9ED4-F97B8B93B93E

Q37540704-40467A9A-304F-4868-A73F-34EA8F65CDD7

Q37540704-7220D5C7-AA0C-45D0-9E49-C21FC98C6130

Q37540704-82B8FE67-11EA-4A4A-BAE8-F276BF4B202A

Q37540704-C783835A-E7F8-4253-A5ED-01E30177AC1C

Q37540704-E6FB15ED-8BB0-4068-9D22-4E36B6E5E1E0

P2860

Q37540704-0B2B3C59-B38C-4907-A3A1-70D78CFDA40C

Q37540704-0D5564A5-362A-4A0E-A9BE-398BAE63E2A0

Q37540704-14CD85BA-3DFF-448C-94D9-DA873C421F54

Q37540704-1B757A3D-A591-4D74-9E0E-6BA45C58118C

Q37540704-32B77F00-90A0-41FF-8F01-1A9D73342A75

Q37540704-3B6CFF04-1B1C-4D20-99EF-8A049EEF74C6

Q37540704-3E3DE618-257E-4703-8593-1AFD023EEB02

Q37540704-41060958-5296-401B-AACE-A2A7128160E1

Q37540704-6ABFE35F-0236-4503-9619-EE4A9E0288E2

Q37540704-88D62755-181F-430D-9A2B-DB456C62C74C

P304

Q37540704-2EC67E70-0770-43BA-BC82-7C217DE1401A

P31

Q37540704-263EC0FB-C66D-4F05-9E86-9B91384DCB5D

P356

Q37540704-D5E536A8-A9C9-4FB8-814F-F2CE5AD4E1F5

P407

Q37540704-085F41E4-0D0A-4052-ACCA-488F91F676D1

P433

Q37540704-3F5D11D5-2AD4-4777-9CC6-3E8CAEA917AA

P478

Q37540704-07386066-0A3D-4516-9784-D3D4AF70633D

P50

Q37540704-74916670-0158-4D9D-8018-CF9BD2C04810

Q37540704-7F16A02B-7B01-4F28-8BF7-049B98DA0206

Q37540704-A36B5470-3D57-49A8-9D7C-F0BCE3EA3B3F

P577

Q37540704-05F1746E-F0F7-4CFE-B1C4-6C3B6DCC225A

P698

Q37540704-4FE38877-4F5D-499F-9FF5-60D28D40E23E

P932

Q37540704-A00428CB-8B4E-4DAA-8076-B416B63126BE

P356

J.YGYNO.2012.05.001

P1433

Gynecologic Oncology

P1476

Outcomes of primary surgical c ...... rade serous ovarian carcinoma.

@en

P2093

Angela G Arnold

http://www.w3.org/2001/XMLSchema#string

David M Hyman

http://www.w3.org/2001/XMLSchema#string

David R Spriggs

http://www.w3.org/2001/XMLSchema#string

Douglas A Levine

http://www.w3.org/2001/XMLSchema#string

Jasmine Bhatia

http://www.w3.org/2001/XMLSchema#string

Kara C Long

http://www.w3.org/2001/XMLSchema#string

Mary F Phillips

http://www.w3.org/2001/XMLSchema#string

Rachel N Grisham

http://www.w3.org/2001/XMLSchema#string

P2860

Integrated genomic analyses of ovarian carcinoma

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis.

Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer

Pathology of ovarian cancers in BRCA1 and BRCA2 carriers.

What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?

Improved survival for BRCA2-associated serous ovarian cancer compared with both BRCA-negative and BRCA1-associated serous ovarian cancer.

The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review.

P304

224-228

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YGYNO.2012.05.001

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

126

http://www.w3.org/2001/XMLSchema#string

P50

Robert A Soslow

Edward J Tanner

P577

2012-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22579790

http://www.w3.org/2001/XMLSchema#string

P932

3909698

http://www.w3.org/2001/XMLSchema#string